IGC Pharma, Inc. Quarterly Other Assets, Noncurrent in USD from Q1 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
IGC Pharma, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q1 2011 to Q2 2024.
  • IGC Pharma, Inc. Other Assets, Noncurrent for the quarter ending June 30, 2024 was $688K, a 32.4% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $688K -$329K -32.4% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $688K -$315K -31.4% Mar 31, 2024 10-Q 2024-08-07
Q4 2023 $999K -$29K -2.82% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 $998K +$48K +5.05% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.02M +$95K +10.3% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1M +$66K +7.04% Mar 31, 2023 10-K 2024-06-24
Q4 2022 $1.03M +$416K +68% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 $950K +$339K +55.5% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $922K +$326K +54.7% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $937K +$334K +55.4% Mar 31, 2022 10-K 2023-07-07
Q4 2021 $612K -$7K -1.13% Dec 31, 2021 10-Q 2022-02-10
Q3 2021 $611K -$5K -0.81% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 $596K -$10K -1.65% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $603K -$7K -1.15% Mar 31, 2021 10-K 2022-06-23
Q4 2020 $619K -$249K -28.7% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 $616K -$251K -29% Sep 30, 2020 10-Q 2020-11-20
Q2 2020 $606K -$289K -32.3% Jun 30, 2020 10-Q 2020-08-19
Q1 2020 $610K -$268K -30.5% Mar 31, 2020 10-K 2021-06-14
Q4 2019 $868K +$81K +10.3% Dec 31, 2019 10-Q 2020-02-10
Q3 2019 $867K +$48K +5.86% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $895K +$435K +94.4% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $878K +$394K +81.4% Mar 31, 2019 10-K 2020-07-13
Q4 2018 $787K -$33.9K -4.13% Dec 31, 2018 10-Q 2019-02-12
Q3 2018 $819K +$127K +18.4% Sep 30, 2018 10-Q 2018-10-16
Q2 2018 $460K -$212K -31.5% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 $484K -$55.7K -10.3% Mar 31, 2018 10-K 2019-06-14
Q4 2017 $821K +$330K +67.2% Dec 31, 2017 10-Q 2018-02-20
Q3 2017 $692K +$188K +37.2% Sep 30, 2017 10-Q 2017-11-17
Q2 2017 $672K +$175K +35.1% Jun 30, 2017 10-Q 2017-08-18
Q1 2017 $540K +$32.4K +6.39% Mar 31, 2017 10-K 2018-06-21
Q4 2016 $491K +$80.8K +19.7% Dec 31, 2016 10-Q 2017-02-21
Q3 2016 $504K +$89.6K +21.6% Sep 30, 2016 10-Q 2016-11-21
Q2 2016 $498K +$70.7K +16.6% Jun 30, 2016 10-Q 2016-08-16
Q1 2016 $507K +$73K +16.8% Mar 31, 2016 10-K 2017-07-14
Q4 2015 $410K -$24.2K -5.57% Dec 31, 2015 10-Q 2016-02-16
Q3 2015 $414K -$31.5K -7.07% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 $427K -$32.9K -7.15% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 $434K -$24.3K -5.3% Mar 31, 2015 10-K 2016-07-14
Q4 2014 $434K +$34K +8.5% Dec 31, 2014 10-Q 2015-02-12
Q3 2014 $446K +$49.9K +12.6% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 $460K +$32.9K +7.7% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 $459K -$7.53K -1.62% Mar 31, 2014 10-K 2015-07-14
Q4 2013 $400K -$577K -59% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 $396K -$651K -62.2% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 $427K -$567K -57% Jun 30, 2013 10-Q 2013-08-16
Q1 2013 $466K -$533K -53.3% Mar 31, 2013 10-K 2014-07-15
Q4 2012 $977K +$731K +296% Dec 31, 2012 10-Q 2013-02-13
Q3 2012 $1.05M +$902K +619% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 $994K +$702K +241% Jun 30, 2012 10-Q/A 2012-08-21
Q1 2012 $999K +$250K +33.4% Mar 31, 2012 10-K/A 2014-07-15
Q4 2011 $247K Dec 31, 2011 10-Q 2012-02-16
Q3 2011 $146K Sep 30, 2011 10-Q 2011-11-18
Q2 2011 $292K Jun 30, 2011 10-Q 2011-08-18
Q1 2011 $749K Mar 31, 2011 10-K 2012-07-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.